YD Bio Limited Ordinary Shares (YDES) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
YD Bio Limited Ordinary Shares (YDES) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $450.5M, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.12 to the broader market. YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. Led by Ethan Shen, public since 2025-08-29.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for YDES as of 2026-10-16; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.